Publications by authors named "R Fishelevich"

Article Synopsis
  • The study examines how different forms of IL-33, particularly mature IL-33 (MIL33) and full-length IL-33 (FLIL33), impact pulmonary fibrosis through their interaction with the ST2 receptor.
  • Genetic deletion of IL-33 or ST2 reduces fibrosis in a bleomycin-induced model, but delivering FLIL33 increases fibrosis effects without activating typical Th2 immune responses.
  • Findings suggest that FLIL33 operates in a way that doesn't rely on ST2 and has different impacts on lung cell behavior compared to MIL33, indicating the potential benefits of targeting both forms for treating pulmonary fibrosis.
View Article and Find Full Text PDF

Some previous studies in tissue fibrosis have suggested a profibrotic contribution from elevated expression of a protein termed either RGCC (regulator of cell cycle) or RGC-32 (response gene to complement 32 protein). Our analysis of public gene expression datasets, by contrast, revealed a consistent decrease in RGCC mRNA levels in association with pulmonary fibrosis. Consistent with this observation, we found that stimulating primary adult human lung fibroblasts with transforming growth factor (TGF)-β in cell cultures elevated collagen expression and simultaneously attenuated RGCC mRNA and protein levels.

View Article and Find Full Text PDF

IL-33 has emerged as a central mediator of immune, inflammatory, and fibrotic responses. Many studies have focused on mature IL-33, but elevated expression of the precursor, full-length IL-33 (FLIL33), has also been implicated in a spectrum of diseases, including tissue fibrosis. We previously reported and now confirmed that overexpression of FLIL33 induced phosphorylation of the key profibrotic signaling mediator of TGF-β, Smad3, in primary human lung fibroblasts from healthy donors and idiopathic pulmonary fibrosis patients.

View Article and Find Full Text PDF

Proteolytic activation of the IL-33 precursor, full-length interleukin-33 (FLIL33), at multiple sites within the sensor domain (aa 95-109) yields several functionally mature (MIL33) forms. Unlike nuclear FLIL33, intracellular MIL33 occurs in the cytoplasm, is secreted from source cells, and exerts biological effects by activating the ST2 receptor on target cells. Previous studies and our findings in this report indicated that IL-33 forms that are substantially longer than those produced by cleavage within the sensor domain are biologically indistinguishable from classical MIL33.

View Article and Find Full Text PDF

Human mature IL-33 is a member of the IL-1 family and a potent regulator of immunity through its pro-T helper cell 2 activity. Its precursor form, full-length interleukin-33 (FLIL33), is an intranuclear protein in many cell types, including fibroblasts, and its intracellular levels can change in response to stimuli. However, the mechanisms controlling the nuclear localization of FLIL33 or its stability in cells are not understood.

View Article and Find Full Text PDF